Taylor Swift and Travis Kelce have an 'endless budget' to dress exactly how they want. Here's what a source said about their ...

Investors can expect more gains for the U.S. stock market in 2025, but should brace for more volatility given already lofty valuations for Wall Street. That’s according to a team of strategists ...

Right now, Brooklinen is having a last-call deal on its classic percale sheets with piped detailing and gray stripes. With a 40% off discount, you can score the almost $200 sheets for just $113.

Wall Street is riding high in the wake of Trump’s win last month. A record percentage of consumers expect stocks to rise over the next year, according to the Conference Board’s latest survey ...

When Gregory Greene retired from his job as chief administrative officer of a Miami-based transportation and logistics company, he realized he didn’t want to manage his retirement money on his own.

Wall Street expects Micron to report revenue of $8.72 billion, 84% higher year-over-year, and for the company to swing to a profit of $1.85 billion or $1.59 per share, compared to a loss of $1.23 ...

Ana Swanson covers trade and reported from Washington. If you ask many a Wall Street investor, tax cuts are poised for extension, deregulation is all but guaranteed, immigration reform for high ...

The outlook for interest rates is getting cloudy as a chorus of analysts on Wall Street suggests the Federal Reserve could signal that its ready to pause interest rate cuts at this week's meeting.

America is now home to eight technology companies with valuations of $1 trillion or more. Broadcom joined the exclusive club last Friday, after revealing incredible growth in its artificial ...

Investors anticipating another calm year in 2025 should be on guard for more shocks like the one seen in August as uncertainty around Donald Trump’s tax and tariff policies threaten to roil ...

Young Wall Street bankers working 90 hours a week are snorting lines of Adderall at their desks in a new office drug culture. While cocaine was once the drug of choice, bankers are now reportedly ...